Pacer Advisors, Inc. Innoviva, Inc. Transaction History

Pacer Advisors, Inc.

$35.5 Billion
Q1 2025

A detailed history of Pacer Advisors, Inc. transactions in Innoviva, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 715,520 shares of INVA stock, worth $13.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

715,520

Previous 2,932,113 75.6%

Holding current value

$13.7 Million

Previous $50.9 Million 74.5%

% of portfolio

0.04%

Previous 0.13%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 06, 2025	SELL	$17.21 - $18.98 $38.1 Million - $42.1 Million	-2,216,593 Reduced 75.6%	715,520 $13 Million
Q4 2024 Jan 22, 2025	BUY	$17.35 - $20.32 $2.1 Million - $2.46 Million	121,162 Added 4.31%	2,932,113 $50.9 Million
Q3 2024 Nov 12, 2024	SELL	$16.33 - $20.04 $8.94 Million - $11 Million	-547,610 Reduced 16.3%	2,810,951 $54.3 Million
Q2 2024 Aug 13, 2024	SELL	$14.4 - $16.4 $33,278 - $37,900	-2,311 Reduced 0.07%	3,358,561 $55.1 Million
Q1 2024 May 10, 2024	BUY	$14.56 - $16.78 $23.8 Million - $27.4 Million	1,631,888 Added 94.38%	3,360,872 $51.2 Million
Q4 2023 Jan 16, 2024	BUY	$12.32 - $16.27 $21.3 Million - $28.1 Million	1,727,534 Added 119140.28%	1,728,984 $27.7 Million
Q3 2023 Nov 13, 2023	SELL	$12.37 - $13.89 $11.6 Million - $13 Million	-938,022 Reduced 99.85%	1,450 $18,000
Q2 2023 Jul 12, 2023	SELL	$11.39 - $13.72 $7.94 Million - $9.57 Million	-697,222 Reduced 42.6%	939,472 $12 Million
Q1 2023 May 02, 2023	BUY	$10.73 - $13.6 $1.05 Million - $1.33 Million	98,040 Added 6.37%	1,636,694 $18.4 Million
Q4 2022 Feb 06, 2023	BUY	$11.8 - $13.78 $746,420 - $871,667	63,256 Added 4.29%	1,538,654 $20.4 Million
Q3 2022 Oct 18, 2022	BUY	$11.61 - $15.22 $4.31 Million - $5.65 Million	371,034 Added 33.6%	1,475,398 $17.1 Million
Q2 2022 Aug 12, 2022	BUY	$14.32 - $19.88 $5.49 Million - $7.62 Million	383,060 Added 53.11%	1,104,364 $16.3 Million
Q1 2022 Apr 05, 2022	BUY	$15.39 - $20.25 $1.1 Million - $1.45 Million	71,559 Added 11.01%	721,304 $14 Million
Q4 2021 Feb 03, 2022	BUY	$15.91 - $18.72 $3.44 Million - $4.04 Million	216,046 Added 49.81%	649,745 $11.2 Million
Q3 2021 Oct 15, 2021	SELL	$13.06 - $17.24 $520,780 - $687,462	-39,876 Reduced 8.42%	433,699 $7.25 Million
Q2 2021 Jul 21, 2021	BUY	$11.45 - $13.96 $2.15 Million - $2.62 Million	187,368 Added 65.47%	473,575 $6.35 Million
Q1 2021 Apr 05, 2021	BUY	$11.06 - $12.87 $2.29 Million - $2.66 Million	206,953 Added 261.13%	286,207 $3.42 Million
Q4 2020 Jan 20, 2021	BUY	$9.33 - $12.48 $320,186 - $428,288	34,318 Added 76.37%	79,254 $982,000
Q3 2020 Oct 19, 2020	BUY	$10.33 - $14.49 $144,599 - $202,831	13,998 Added 45.25%	44,936 $470,000
Q2 2020 Jul 29, 2020	BUY	$11.49 - $15.26 $77,511 - $102,943	6,746 Added 27.89%	30,938 $433,000
Q1 2020 Apr 23, 2020	SELL	$8.11 - $15.23 $331,358 - $622,267	-40,858 Reduced 62.81%	24,192 $317,000
Q4 2019 Feb 10, 2020	SELL	$10.28 - $14.38 $104,650 - $146,388	-10,180 Reduced 13.53%	65,050 $921,000
Q3 2019 Oct 10, 2019	BUY	$10.05 - $14.55 $179,563 - $259,964	17,867 Added 31.15%	75,230 $793,000
Q2 2019 Aug 12, 2019	SELL	$13.1 - $14.95 $125,065 - $142,727	-9,547 Reduced 14.27%	57,363 $835,000
Q1 2019 Apr 10, 2019	BUY	$13.69 - $20.06 $351,655 - $515,281	25,687 Added 62.31%	66,910 $939,000
Q4 2018 Feb 13, 2019	BUY	$13.96 - $18.26 $151,661 - $198,376	10,864 Added 35.79%	41,223 $719,000
Q3 2018 Nov 14, 2018	BUY	$13.63 - $15.7 $280,846 - $323,498	20,605 Added 211.25%	30,359 $463,000
Q2 2018 Aug 14, 2018	BUY	$13.44 - $17.59 $83,798 - $109,673	6,235 Added 177.18%	9,754 $135,000
Q1 2018 May 14, 2018	BUY	$13.8 - $16.99 $13,455 - $16,565	975 Added 38.33%	3,519 $59,000
Q4 2017 Feb 14, 2018	BUY	$11.73 - $14.75 $29,841 - $37,524	2,544	2,544 $36,000

Others Institutions Holding INVA

# of Institutions

256

Shares Held

75M

Call Options Held

2.3K

Put Options Held

2.4K

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Innoviva, Inc. Transaction History